Drug-implantable cardioverter–defibrillator interactions

descriptionPublicationkeyboard_double_arrow_right Article 01 Sep 2010 English Publisher:Informa UK LimitedJournal:Expert Review of Cardiovascular Therapy, volume 8, pages 1,267-1,273 (issn: 1477-9072, eissn: 1744-8344,

Copyright policy )

Authors: Roger, Beadle; Lynne, Williams; Hoong Sern, Lim;

doi: 10.1586/erc.10.114

pmid: 20828349

Drug-implantable cardioverter–defibrillator interactions

- Summary
- Subjects
- Metrics

Abstract

Antiarrhythmic drugs are commonly used synergistically with implantable cardioverter defibrillators in the management of ventricular and supraventricular arrhythmias. However, these drugs may directly or indirectly interact with device function. In addition, expanding indications for implantable cardioverter defibrillators, particularly in patients with multiple comorbidities, further increases the potential for drug-device interactions. These potential drug-device interactions are summarized in this article.

Related Organizations

University of Birmingham
United Kingdom
University of Aberdeen
United Kingdom

Keywords

Humans, Arrhythmias, Cardiac, Anti-Arrhythmia Agents, Combined Modality Therapy, Defibrillators, Implantable

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average